'A Single-Center Study Experience with Children Newly Diagnosed with Immune Thrombocytopenia and the Difficulty in Application of the 'Watch and Wait' Approach'

We prospectively studied the course, laboratory findings and the application of the 'watch and wait' approach of 45 children with newly diagnosed immune thrombocytopenia (ITP). The study group was divided in two subgroups: The newly diagnosed/persistent and the chronic group. Patients' median age was 54 (1.4-180) months. In the newly/persistent subgroup the boys were 19 (48.72%) while in the chronic subgroup they were 5 (83.33%).